JPMorgan Chase & Co’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.7K | Buy |
+12,483
| New | +$48.7K | ﹤0.01% | 5107 |
|
|
2024
Q4 | – | Sell |
-27
| Closed | -$113 | – | 6355 |
|
|
2024
Q3 | $113 | Buy |
+27
| New | +$113 | ﹤0.01% | 5912 |
|
|
2024
Q1 | – | Sell |
-564
| Closed | -$1.6K | – | 6425 |
|
|
2023
Q4 | $1.6K | Buy |
564
+539
| +2,156% | +$1.53K | ﹤0.01% | 5716 |
|
|
2023
Q3 | $65 | Buy |
25
+4
| +19% | +$10 | ﹤0.01% | 5998 |
|
|
2023
Q2 | $91 | Buy |
+21
| New | +$91 | ﹤0.01% | 5797 |
|
|
2021
Q3 | – | Sell |
-8,299
| Closed | -$37K | – | 5552 |
|
|
2021
Q2 | $37K | Buy |
+8,299
| New | +$37K | ﹤0.01% | 5014 |
|
|
2020
Q4 | – | Sell |
-8
| Closed | – | – | 4920 |
|
|
2020
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 4828 |
|
|
2020
Q2 | $0 | Buy |
+8
| New | – | ﹤0.01% | 4768 |
|